I have some comments to make.
Thank you for being here.
Following up on Ms. Kiddell-Monroe's comment, I must admit that problems do exist. First of all, people are dying. Second of all, money is an issue. In addition, as you said at the beginning, we are currently part of an almost undemocratic process because sponsorship is not ensured.
The first step would be to at least refer the bill to the House, so that the matter can be decided. However, serious doubts could arise, as some people might have different goals in mind.
The bottom line is that people are dying. Money is also a problem. You mentioned the Global Fund to Fight AIDS, Tuberculosis and Malaria, which is set at $13 billion a year. You say that Canada is contributing. We were told last week that Canada contributes $150 million or $160 million to the fund, which is about 1% of the total amount.
Companies also worry about money, but they often forget that dying people will never buy highly priced drugs. That much is obvious. How much could pharmaceutical companies contribute to the cause? Either way, they will never sell those people anything. Consequently, they might as well sell their products at no profit, or even at a small loss.